There are 2,478 results relating to "Acheter L"
Order by
|
SPICe briefings
Date published:
30 April 2024
Scottish Languages Bill - Language Shift, Maintenance and Revitalisation
Different authors in the field of language revitalisation have emphasised different approaches. Hinton (2011)3Hinton, L. (2011). The Cambridge Handbook of Endangered Languages , pp. 291 - 311.
SPICe briefings
Date published:
19 August 2021
Land Use and Rural Policy: Subject Profile - Nature-based Solutions
Stafford, R., Chamberlain, B., Clavey, L., Gillingham, P., McKain, S., Morecroft, M., … Watts, O. (2021).
Last updated:
11 December 2023
UKSI Official Controls etc Regulations 2023 of 6 November 2023
L., Pyrus L., Ribes L., Papaws (papayas) Rubus L., Syzygium fresh or chilled.
SPICe briefings
Date published:
28 October 2025
Scotland's water industry: overview of regulation and key challenges - 6.2.1 Reducing water consumption
This indicates that individuals concerned about the environment do not connect actions to conserve water with climate change.1Ashworth, L. (2023, December). Supporting sustainable water use among Scotland's consumers.
SPICe briefings
Date published:
11 October 2021
Addressing the nature crisis: COP15 and the global post-2020 Biodiversity Framework - Biodiversity loss and climate change - twin crises
Renewable and Sustainable Energy Reviews. doi: 10.1016/j.rser.2016.08.0304 Bergström, L., Kautsky, L., Malm, T., Rosenberg, R., Wahlberg, M., Åstrand Capetillo, N., … Wilhelmsson, D. (2014).
Committees
Published:
4 June 2021
Jerry Mulders submission of 4 June 2021
PE1864/L Jerry Mulders submission of 4 June 2021.
SPICe briefings
Date published:
26 April 2019
Scottish National Investment Bank Bill - Characteristics of national investment banks
An international comparison of national investment banks and patient finance4Macfarlane, L., & Mazzucato, M. (2018, February).
SPICe briefings
Date published:
18 September 2018
Buying a home - Scottish Government support - Barriers to home ownership
Other barriers cited included the rising cost of living, properties in the area being too expensive and job insecurity.1Marshall, L., Wishart, R., & Smith, N. (2017, October 4).
Last updated:
19 April 2023
NHS Borders Evidence Pack
Dec-22 111 Jan-23 64 ae decision to treat M Referral to Treatment (RTT) - % 90% patient to be seen and treated within 18 weeks of n ↑ Dec-22 67.9% Jan-23 88.4% al treated within 18 weeks of referral referral. P l Diagnostics (8 key tests) - Number Zero patients waiting longer than 6 weeks for 8 key a ↑ Dec-22 1202 Jan-23 1073 n waiting >6 weeks diagnostic tests oita CAMHS- % treated within 18 weeks of r ↓ 90% patients seen and treated within 18 weeks of referral Nov-22 31.3% Dec-22 30.8% e referral pO A&E 4 Hour Standard - Patients l 95% of patients seen, discharged or transferred within 4 a ↑ discharged or transferred within 4 Dec-22 63.5% Jan-23 64.7% hours u hours nn Delayed Discharges - Patients A ↑ Zero patients delayed in hospital for more than 72 hours Dec-22 33 Jan-23 45 delayed over 72 hours Psychological Therapies - % treated ↓ 90% patient treated within 18 weeks of referral Nov-22 84.1% Dec-22 81.3% within 18 weeks of referral Drug & Alcohol - Treated within 3 ↔ 90% patient treated within 3 weeks of referral Nov-22 100% Dec-22 100% weeks of referral ↑ Sickness Absence Rates Maintain overall sickness absence rates below 4% Dec-22 6.41% Jan-23 6.91% 14 Cancer Waiting Times (please note there is a 1-month lag time for data) Fig. 9 95% of suspicion of cancer cases seen within 62 Days Percentage Mean UCL LCL Standard % 120% 110% 100% 90% 80% 70% 60% 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 9 0 1 2 3 1 1 2 2 2 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p n n n n n n n n n n c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S D D D D D A A A A A N N N N N M M M M M M M M M Fig. 10 95% of cancer treatment patients treated within 31 Days Percentage Mean UCL LCL Standard % 105% 100% 95% 90% 85% 80% 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 9 0 1 2 3 1 1 2 2 2 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p n n n n n n n n n n c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S D D D D D A A A A A N N N N N M M M M M M M M M 15 Stage of Treatment- Outpatients Waiting Over 12 Weeks Stage of Treatment Target - Outpatients Waiting Over 12 Weeks 12wks Mean UCL LCL 8000 7000 6000 5000 4000 3000 2000 10000 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 9 0 1 2 3 1 1 2 2 2 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n -1000 c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M Fig. 11 16 Stage of Treatment- Inpatients Waiting Over 12 Weeks Stage of Treatment Target - Inpatients Waiting Over 12 Weeks 12wks Mean UCL LCL 2500 2000 1500 1000 5000 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 9 0 1 2 3 1 1 2 2 2 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M Fig. 12 17 Patients Treated within the 12 weeks Treatment Time Guarantee Patients Treated within the 12 weeks Treatment Time Guarantee 12wks TTG Mean UCL LCL 250 200 150 100 500 -50 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 8 9 0 1 2 9 0 1 2 8 9 0 1 2 9 0 1 2 3 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M Fig. 13 18 18 Weeks Referral to Treatment Combined Pathway Performance 18 Weeks Percentage Referral to Treatment Combined Pathway Performance Percentage Mean UCL LCL Standard % 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 3 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n u u u u u c c c c c a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M Fig. 14 19 Diagnostic Waits Diagnostics Waits over 6 Weeks Number over 6 weeks Mean UCL LCL 2000 1800 1600 1400 1200 1000 800 600 400 2000 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 8 9 0 1 2 9 0 1 2 3 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n u u u u u c c c c c a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M Fig. 15 20 CAMHS Waiting Times- 18 Week Referral to Treatment 18 Week Referral to Treatment for CAMHS Percentage Mean UCL LCL Standard % 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 8 9 0 1 2 9 0 1 2 3 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p n n n n n n n n n n u u u u u c c c c c a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S D D D D D A A A A A N N N N N M M M M M M M M M Fig. 16 21 Psychological Therapies Waiting Times- 18 Week Referral to Treatment 18 Week Referral to Treatment for Pyschological Therapies Percentage Mean UCL LCL Standard % 110% 90% 70% 50% 30% 10% -10% 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 9 0 1 2 3 1 1 2 2 2 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p n n n n n n n n n n c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S D D D D D A A A A A N N N N N M M M M M M M M M Fig. 17 22 Delayed Discharges Fig. 18 23 Fig. 19 DDs at Census Delayed over 72 Hours DDs over 72 hours (3 days) Mean UCL LCL 70 60 50 40 30 20 100 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 3 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n u u u u u c c c c c a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M Fig. 20 Standard Delayed Bed Days Standard Delayed Bed Days Mean UCL LCL 2000 1500 1000 5000 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 8 9 0 1 2 9 0 1 2 3 1 2 2 2 1 1 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n u u u u u c c c c c a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N M M M M M M M M M 24 Drugs & Alcohol 3 Week Drugs and Alcohol Referral to Treatment Percentage Mean UCL LCL Standard % 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 9 0 1 2 9 0 1 2 1 1 2 2 2 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r r r r r c c c c c y y y y y v v v v v g g g g g p b p b p b p b p n n n n n n n n n c c c c c u u u u u a a a a p p p p p e e e e e a a a a a o o o o o u u u u u a a a a e e e e e e e e e u u u u u J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S D D D D D A A A A A N N N N N M M M M M M M M M Fig. 21 25 Number of Alcohol Brief Interventions Delivered Trajectory Tolerance 2018/19 2020/21 2019/20 2020/21 2021/22 2022/23 2500 2000 1500 1000 5000 Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Fig. 22 26 Sickness Absence Sickness Absence Percentage below 4% 8% Percentage Mean UCL LCL Standard % 6% 4% 2% 0% … … … … … … … … … - - - - - - - - - 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 0 1 2 8 9 9 0 0 1 1 2 2 3 8 9 0 1 2 8 9 0 1 2 9 0 1 2 3 r r r r y y y y y 1 2 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 2 2 2 1 1 1 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 2 a a a a a a a a a - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l l l t t t t t r r r r r c c c c c v v v v v g g g g g p b p b p b p b p b n n n n n n n n n n M M M M c c c c c u u u u u M M M M M p p p p p e e e e e o o o o o u u u u u a a a a a e e e e e e e e e e u u u u u J J J J J J J J J J J J J J J O O O O O A A A A A S F S F S F S F S F D D D D D A A A A A N N N N N Fig. 23 Covid Absence Percentage Percentage Mean UCL LCL 6% 5% 4% 3% 2% 1% 0% -1% 0 1 2 0 1 2 0 1 2 0 1 2 0 1 1 2 2 3 0 1 2 0 1 2 0 1 2 1 2 0 1 2 1 2 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - l l l t t t r r r r r c c c y y y v v v g g g p b p b p b n n n n n n u u u c c c a a p p p e e e a a a o o o u u u a a a e e e e e e u u u J J J J J J J J J O O O A A A S F S F S F D D D A A A N N N M M M M M Fig. 24 27 Smoking Quits (Please Note: All figures are cumulative.
SPICe briefings
Date published:
27 June 2022
Judicial Review - Key stages of a judicial review action
First, there is the permission stage, a significant hurdle to clear in practice,1Drummond, L., McCartney, F., & Poole, A. (2020).
